Pernix Therapeutics, Inc. Reports Second Quarter 2010 Results

August 17, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MAGNOLIA, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company primarily focused on the pediatric market, today announced results for the quarter and six months ended June 30, 2010.

Twitter
LinkedIn
Facebook
Email
Print

Earnings